Clinical trials: Post-stroke Lymphocytopenia
Large Infarct Core, Post-stroke Lymphocytopenia
Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia
The efficacy and safety of early adjunctive methylprednisolone therapy in acute ischemic stroke patients with large infarct cores (ASPECTS score < 6) and post-stroke lymphocytopenia remain unclear.
- Trial name
- MIRACLE-2 (NCT07202143)
- Testing
- Methylprednisolone sodium succinate, Normal Saline
- Where
- China
- Volunteers
- 200 people
- Sponsor
- YiLin